Averse Effects of Intravenous Immunoglobulin Therapy

Abstract

Get full access to this article

View all access options for this article.

References

1. Stiehm ER . Recent progress in the use of intravenous immunoglobulin. Curr ProblPediatr. 1992;22:335-348.

2. NIH Consensus: intravenous immunoglobulin; prevention and treatment of disease.JAMA. 1990;264:3189-3193.

3. Intravenous immunoglobulin use in children. Can MedAssocj. 1992;146:121-124.

4. Buckley RH , Schiff RI . The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med. 1991;325:110-117.

5. Intravenous immune globulin for the prevention of bacterial infections in children with asymptomatic human immunodeficiency virus infection [Abstract] . The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. NEnglJMed. 1991;325:73-3193.

6. Rousell RH , Dodkin MB , Budinger MD . Transmission of hepatitis after the administration of intravenous immunoglobulins. AmJ Clin PathoL 1993;99:649-649.

7. Mitra G , Dobkin MB , Budinger MD , Lourie RE . Elimination of infectious retroviruses during preparation of immunoglobulins. Transfusion. 1986;26: 394-397.

8. Dwyer JM . Intravenous therapy with gamma globulin. Adv Intern Med. 1987;32:111-135.

9. Miller KB , Scheunkein DP , Wasserman RL . Safety and tolerability of an intravenous immune globulin at various concentrations in 5% dextrose injection or sterile water for injection. Clin Pharm. 1992;7:628-631.

10.

10. Ippoliti C , Williams LA , Huber S . Toxicity of rapidly infused concentrated intravenous immune globulin. Clin Pharm. 1992;11:1022-1026.

11.

11. Rao SP , Teitlebaum J , Miller ST . Intravenous immune globulin and aseptic meningitis. Am J Dis Child. 1992;146: 539-540.

12.

12. Pallares DE , Marshall GS . Acute aseptic meningitis associated with administration of intravenous immune globulin. AmJPed Hematol OncoL 1992;14:279-279.

13.

13. Molina JM , Coffineau A , Rain JD , Letowturierr AM . Aseptic meningitis following administration of intravenous immune globulin. Clin InfectDis. 1992;15:564-565.

14.

14. Castells-Van Daele M , Wijndaele L , Hunnick K . Intravenous immune globulin and acute aseptic meningitis. NEnglJMed. 1990;323:614-615.

15.

15. Kressebuch H , Schaad UB , Hurt A , Bianchetti MG . Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. Pediatr Infect Dis J. 1992;11:894-895.

16.

16. Meiner Z , Ben-Hur T , River Y , Reckes A . Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis.JNeurolNeurosurg Psychiatry. 1993;56:830-831.

17.

11. Rao SP , Teitlebaum J , Miller ST . Intravenous immune globulin and aseptic meningitis. Am J Dis Child. 1992;146: 539-540.

18.

12. Pallares DE , Marshall GS . Acute aseptic meningitis associated with administration of intravenous immune globulin. AmJPed Hematol OncoL 1992;14:279-279.

19.

13. Molina JM , Coffineau A , Rain JD , Letowturierr AM . Aseptic meningitis following administration of intravenous immune globulin. Clin InfectDis. 1992;15:564--.

20.

14. Castells-Van Daele M , Wijndaele L , Hunnick K . Intravenous immune globulin and acute aseptic meningitis. NEnglJMed. 1990;323:614--.

21.

15. Kressebuch H , Schaad UB , Hurt A , Bianchetti MG . Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. Pediatr Infect Dis J. 1992;11:894--.

22.

16. Meiner Z , Ben-Hur T , River Y , Reckes A . Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis.JNeurolNeurosurg Psychiatry. 1993;56:830-831.

23.

17. Vera-Ramirez M , Charlet M , Parry CJ . Recurrent aseptic meningitis compliating intravenous immunoglobulin therapy for chronic inflammation demyelinating polyradiculoneuropathy. Neurology. 1992;42:1636-1637.

24.

18. Mitterer M , Pescosta N , Vogetseder W , et al. Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura. Ann Hematol2. 1993;67:151-152.

25.

19. Hague RA , Eden OB , Yap PL , et al. Hyperviscosity in HIV infected children a potential hazard during intravenous immunoglobulin therapy. Blut. 1990;61: 66-67. Abstract.

26.

20. Martin CM , Matlow AG , Chew E , et al. Hyperviscosity syndrome in a patient with acquired immunodeficiency syndrome. Arch Intern Med. 1989;149:1435-1436.

27.

21. Gilbert PL , Knezevic WV , Bridge DT . Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis. Neurology. 1992;42:257-258.

28.

22. Schifferli J , Leski M , Favre HN , etal. Highdose intravenous IgG treatment and renal function. Lance7 1991;337:457-458.

29.

23. Rault R , Piraino B , Johnston JR , Oral A . Pulmonary and renal toxicity of intravenous immunoglobulin. Clin Nephrol. 1991;36:83-86.

30.

24. Donatini B . Transient renal dysfunction in diabetic patients after IVIG therapy. JIntern Med. 1992;232:376-376.

31.

25. Kobosko J , Nicol P . Renal toxicity of intravenous immunoglobulin. Clin Nephrol. 1992;37:216-217.

32.

26. Phillips AO . Renal failure and intravenous immunoglobulin. Clin NephroL 1992;37:217-217.

33.

27. Moran M , Kapsner C . Acute renal failure associated with elevated plasma oncotic pressure. NEnglJMed. 1987;317:150-152.

34.

28. Tan E , Hajinazarian M , Bay W , et al. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol. 1993;50:137-139.

35.

29. Barandun S . Replacementtherapyin primary immunodeficiencies. In: Nydegger UE , Morrel A , eds. Clinical Uses of Intravenou. s Immunoglobulins. London, UK Academic Press; 1986:63-67.a

36.

30. Comenzo R , Malachowski ME , Meissner HC , et al. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr. 1992;120:926-928.

37.

31. Copelan EA , Strohm PL , Kennedy MS , Tutschk PJ . Hemolysis following intravenous immune globulin therapy. Transfusion. 1986;26:410-412.

38.

32. Moscow JA , Casper AJ , Kodis C , Fricke WA . Positive direct antiglobulin test results after intravenous immune globulin administration. Transfusion. 1987; 27:248-249.

39.

33. Salama A , Mueller-Eckhardt C , Kiefel V . Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet. 1983;2(8343):193-195.

40.

34. Brox AG , Cournoyer D , Sternbach M , Spurll G . Hemolytic anemia following intravenous gamma globulin administration. AmJMed. 1987;82:633-635.

41.

35. Ben-Chetrit E , Putterman C . Transient nettropenia induced by intravenous gamma globulin. N Engl J Med. 1992; 326:270-271.

42.

36. Lassiter HA , Bubb ICW , Bertolone SJ , et al. Neonatal immune neutropenia following the administration of intravenous immune globulin. AmJPediatrHematol OncoL. 1993;15:120-123.

43.

37. Woodruff RK , Grigg AP , Firkin FC , Smith IL . Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet. 1986;2 (8500):217-218.

44.

38. Frame WD , Crawford RJ . Thrombotic events after intravenous immunoglobulin. Lancet. 1986;2(8504):468-468.

45.

39. Lane RS . Non-A, non-B hepatitis from intravenous immunoglobulin. Lancet. 1983;2 (8356):974-975.

46.

40. WebsterADB , LeverAML . Non-A, non-B hepatitis after intravenous gammaglobulin. Lancet. 1986;1 (8476):322-323.

47.

41. Lever AML , Brown D , Webster ADB , Thomas HC . Non-A, non-B hepatitis occurring in agammaglobulinemic patients after intravenous immunoglobulin. Lancet. 1984;2(8411):1062-1064.

48.

42. Intravenous immune globulin . Med Lett Drug Ther. 1992;34:116-118.

49.

43. Vallari DS , Jett BW , Alter HJ , et al. Serological markers of post-transfusion hepatitis C viral infection. J Clin MicrobioL. 1992;30:552-556.

50.

44. Imbach P , Perret BA , Bobington R , et al. Safety of intravenous immunoglobulin preparations: a prospective multicenter study to exclude the risk of non-A, non-B hepatitis. Vox Sang. 1991;61:240-243.

51.

45. Rodell MB , Bergman GE . Safety of immune globulin preparations with regard to human immunodeficiency virus.JInfectDis. 1990;162:997-997.

52.

46. Sugitani M , Inchauspe G , Slundo M , Prince AM . Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet. 1992;339:1018-1019.

53.

47. Dodd RY Hepatitis C virus , antibodies and infectivity. Paradox, pragmatism and policy. AmJPathoL 1992;97:4-6. Editorial.

54.

48. Yu MW , Masou BL , Guo ZP , et al. Hepatitis C transmission associated with intravenous immunoglobulins. Lancet. 1995;345:1173-1174.

55.

49. Nubling CM , Willkommen H , Lower J . Hepatitis C transmission associated with intravenous immunoglobulins. Lancet. 1995;345:1174-1174.

56.

50. Bjoro K , Froland SS , Yun Z , et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globin. NEnglJMed. 1994; 331:1607-1611.

57.

51. Iwarson S , Wejst'l R , Ruttimann E . Non-A, non-B hepatitis associated with th-e administration of intravenous immunoglobulin transmission studies in chimpanzees. Serodiag Immunother. 1987;1: 261-266.

58.

52. CDC . Outbreak of hepatitis C associated with intravenous immunoglobulin administration. United States, October 1993-June 1994. MMVWR. 1994;43:505-509.

59.

53. Horowitz B , Prince AM , Horowitz MG , Watklevicz C . Viral safety of solvent-detergent treated blood products. Dev Biol Stand. 1993;81:147-161.

60.

54. Taliane G , Guerra E , Rosso R , et al. Hepatitis C virus infection in hypogammaglobulinemic patients receing longterm replacement therapy with intravenous immunoglobulin. Transfusion. 1995;32:103-107.

61.

55. Schiano TD , Bellary SV , Black M . Possible transmission of hepatitic C virus infection with intravenous immunoglobulin. Ann Intern Met. 1995;122:802-803.

62.

56. Burks AW , Sampson HA , Buckley RH . Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. NEnglJMed. 1986;314:560-564.

63.

57. Chan-Lam D , Fitzsimons EJ , Douglas WS . Alopecia after immunoglobulin infusion. Lancet. 1987;1 (8543):436-436.

64.

58. Ayliffe W , Haeney M , Roberts SC , Lavin M . Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy. Lancet. 1992;339:558-559.

65.

59. Berkman SA , Lee ML , Hale RP . Clinical uses of intravenous immunoglobulins. Ann Intern Med. 1990;112:278-292.

66.

60. Craig TJ , Davis W . Hepatitis associated with high-dose intravenous gammaglobulin. Ann Allergy. 1993;71:276-276.

67.

61. Schiff RI , Buckley RH , Sedlak D . Rapid infusion of sandoglobulin (R) in patients with primary humoral immunodeficiency [Abstract]. In: Imbach P , ed. Immunotherapy with Intravenous Immunoglobulins. London, UK Harcourt Brace Jovanovich; 1991:437-438.

68.

62. Lederman HM , Roifman CM , Lavi S , Gelfand EW . Corticosteroids for prevention of adverse reactions to intravenous immune serum globulin infusions in hypogammaglobulinemic patients. AmJMed. 1986;81:443-446.